Theravance biopharma inc

Major-Pharmaceuticals

TBPH


Ugland House
George Town , KY1-1104

Executive/
Director

Price

  • Last Close
  • $ 9.99
    $ +1.76 21.39 %
    Dec 9, 2024
  • 52-Week High/Low
  • $11.59 - $7.66
  • YTD
  • -11.1%

  • Trading Volume
  • 10,935
  • Market Cap Full
  • $ 497.5M
  • Shares Outstanding
  • 49.8M
    Nov 1, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 16.3% 14.7% 15.5% -13.1% -11.4% -5% 16.2% -13.5% -3.3% -20.2%
Q2 -25% 20.7% 8.2% -3.4% -30.9% 4% -28.9% -5.2% -4.6% 0.8%
Q3 -15.6% 59.7% -14.1% 43.1% 19.4% 8% -49% 11.9% -16.6% -
Q4 49.1% -12% -21.1% -23% 33.4% 18.8% 49.3% 10.7% 29.5% -
J F M A M J J A S O N D
2024 -15.7% -0.1% -5.3% 1.5% - - - - - - - -
2023 -3.7% -0.1% 0.5% -0.2% 3.2% -7.4% -4.4% -3.7% -9.4% 9.4% 11% 7.3%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%10%95%-13%-8%2%-33%-37%2%0%-11%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 1.29 1.10 1.27 -1.22 -1.32 -1.4 -1.24 -0.34 -0.35
Q2 1.42 1.06 1.27 -0.76 -0.72 -1 -0.8 -0.11 -0.28
Q3 1.40 0.73 1.27 -1.1 -1.05 -1.16 -0.48 12.14 -0.17
Q4 1.23 1.36 1.64 -0.91 -1.16 -0.9 -0.35 0.16 -
A 5.3 4.3 5.5 -4 -4.3 -4.5 -2.9 11.9 -0.8

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 55.6 62.5 64.3 74.7 62.9
Jun 54.9 56.1 63.1 65.3 76.1 57.8
Sep 55.1 56.6 63.5 73.5 76.4 52.8
Dec 55.4 56.8 64 73.7 67.4 49.8

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 0.2 0.6 2.3 3 2.2
Total Asset Turnover 0.1 0.2 0.2 0.2 0.1
Leverage
Debt Ratio - 1.5 1 0.7 0.4
Debt – Equity Ratio - -1.1 -1.2 -1 -4.4
Interest Coverage 0.1 4.4 14.9 15.8 10.4
Equity multiplier 0.5 -0.3 -0.1 -0.1 -0.5